2010
DOI: 10.1016/j.neuroscience.2009.10.066
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotection of locomotor networks after experimental injury to the neonatal rat spinal cord in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
19
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 21 publications
(22 citation statements)
references
References 42 publications
3
19
0
Order By: Relevance
“…Full details of the experimental methods have recently been published (Taccola et al 2008;Margaryan et al 2010). In brief, we used neonatal (age: 0-2 days) rat spinal cords with the following protocols: sham preparations were maintained in vitro for up to 24 h in standard Krebs solution (Taccola et al 2008); injured preparations were treated with a maximally effective dose (1 mM) of the glutamate agonist kainate (60 min) followed by wash and maintenance in Krebs solution for 24 h. PHE (60 lM; Sigma, Milan, Italy)-treated preparations received this drug either at the time of kainate washout or after the first 30 min of kainate application.…”
Section: Methodsmentioning
confidence: 99%
“…Full details of the experimental methods have recently been published (Taccola et al 2008;Margaryan et al 2010). In brief, we used neonatal (age: 0-2 days) rat spinal cords with the following protocols: sham preparations were maintained in vitro for up to 24 h in standard Krebs solution (Taccola et al 2008); injured preparations were treated with a maximally effective dose (1 mM) of the glutamate agonist kainate (60 min) followed by wash and maintenance in Krebs solution for 24 h. PHE (60 lM; Sigma, Milan, Italy)-treated preparations received this drug either at the time of kainate washout or after the first 30 min of kainate application.…”
Section: Methodsmentioning
confidence: 99%
“…Neuronal nuclei (NeuN) monoclonal antibody has been widely used in our lab (Taccola et al 2008;Margaryan et al 2009Margaryan et al , 2010 as a reliable tool to detect differentiated neurons: its neuronal target has been recently identified as Fox-3 (Kim et al 2009). In the present study, we used NeuN to assess the number of surviving neurons after excitotoxicity.…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…The protocol of the present experiments was similar to the one of our previous reports (Taccola et al 2008;Margaryan et al 2010) and consisted of applying a temporary, strong excitotoxic stimulus (such as kainate) to find out what happened (and to what cells and for how long) after removal of the excitotoxic agent. This in vitro model was, therefore trying to imitate, despite its intrinsic limitations (lack of vascular supply and of immune system responses), the rapid evolution of acute spinal injury in vivo, in which excitotoxicity is believed to be an early strong contributor to the severe network damage (Choi 1992;Hall and Springer 2004;Park et al 2004).…”
Section: An In Vitro Model Of Spinal Network Damage Induced By Kainatmentioning
confidence: 99%
See 1 more Smart Citation
“…The acute phase of SCI (due to the primary insult of mechanical, vascular or dysmetabolic nature) rapidly evolves into secondary damage, characterized by excitotoxicity caused by massive release of glutamate, in turn triggering a complex pathophysiological cascade generating toxic compounds (Dumont et al, 2001;Park et al, 2004;Rowland et al, 2008;Forder and Tymianski, 2009;Fatima et al, 2014). Thus, neuroprotection against secondary injury is a major therapeutic target (York et al, 2013;Cox et al, 2014) to preserve the spinal gray (Lipton, 2006;Sa´mano et al, 2012) and white matter containing the long-fiber tracts (Kanellopoulos et al, 2000;Lee et al, 2008;Margaryan et al, 2010;Sun et al, 2010;Cox et al, 2014). Large-scale clinical trials proposed the early i.v.…”
Section: Introductionmentioning
confidence: 99%